Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (Abeta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Abeta earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Abeta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Abeta clearance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The protective function of Ly6Clo monocytes in AD may also explain why CCR2 deficiency exacerbates disease severity [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“CCR2 deficiency worsened AD pathology [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“studies utilizing whole body irradiation chimeras, an experimental technique that is now recognized to condition the brain for monocyte infiltration [2, 3, 230], as well as transplant of BM-derived cells, reported that Ly6Chi monocytes infiltrate the AD mouse brain and accumulate around Aβ plaques.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“These infiltrating cells were thought to ameliorate disease evolution by phagocytosis and clearance of Aβ from the brain parenchyma [287] or by promotion of CCR2-mediated microglial accumulation in amyloid plaques and degradation of Aβ [89].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“Marrow-derived cells may have an ameliorative effect on neurodegenerative phenotypes in mice33,34, possibly due to their superior phagocytic capacity35.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [34]
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Chemokines are chemotactic cytokines that bind specific G protein–coupled receptors on the surface of cells and mediate the accumulation of leukocytes at sites of inflammatio”
BackgroundBard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Cited by
Items 701–800 of 940
Steffen, J., Stenzel, J., Ibrahim, S. M., & Pahnke, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180395 · Cited by 12
Guttman, O., & Lewis, E. C. (2016) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000204 · Cited by 11
Cross-Talk and Subset Control of Microglia and Associated Myeloid Cells in Neurological Disorders
Mills, J., Ladner, L. R., Soliman, E., Leonard, J. W., Morton, P. D., & Theus, M. H. (2022) · Cells · doi:10.3390/cells11213364 · Cited by 10
Cysteine-rich granulin-3 rapidly promotes amyloid-β fibrils in both redox states
Bhopatkar, A. A., Ghag, G., Wolf, L. M., Dean, D. N., Moss, M. A., & Rangachari, V. (2019) · Biochemical Journal · doi:10.1042/bcj20180916 · Cited by 10
Up-regulated inflammatory signatures of the spinal cord in canine degenerative myelopathy
Hashimoto, K., Kobatake, Y., Asahina, R., Yamato, O., Islam, M. S., Sakai, H., Nishida, H., Maeda, S., & Kamishina, H. (2020) · Research in Veterinary Science · doi:10.1016/j.rvsc.2020.11.001 · Cited by 11
Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions
Li, L., Wang, Y., Feng, Q., Ma, C., He, C., Wan, W., & Tang, L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251335572 · Cited by 11
Almalki, W. H., & Almujri, S. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155614 · Cited by 9
Hohsfield, L. A., Ehrlich, D., & Humpel, C. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23309 · Cited by 9
PrP106-126 and Aβ1-42 Peptides Induce BV-2 Microglia Chemotaxis and Proliferation
Tu, J., Yang, L., Zhou, X., Qi, K., Wang, J., Kouadir, M., Xu, L., Yin, X., & Zhao, D. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0140-3 · Cited by 9
Alexakou, E., Bakopoulou, A., Apatzidou, D. A., Κritis, A., Malousi, A., & Anastassiadou, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010005 · Cited by 9
Chen, J., Li, Q., Zhu, J., Yuan, Z., Wang, T., & Song, J. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00408-z · Cited by 9
Malm, T., Magga, J. M., & Koıstınaho, J. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-011-0004-z · Cited by 9
Correlation Analysis between External Factors and Students’ Physics Learning Achievement
Karyadi, K., Sinon, I. L. S., Yusuf, I., & Widyaningsih, S. W. (2018) · Scientiae Educatia · doi:10.24235/sc.educatia.v7i1.2415 · Cited by 10
Neuropathological links between T2DM and LOAD: systematic review and meta-analysis
Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 11
Savchenko, E., Malm, T., Konttinen, H., Hämäläinen, R. H., Guerrero-Toro, C., Wojciechowski, S., Giniatullin, R. A., Koıstınaho, J., & Magga, J. M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00279 · Cited by 10
Taraschenko, O. D., Fox, H. S., Eldridge, E., Heliso, P., Al‐Saleem, F. H., Dessain, S. K., Casale, G. P., Willcockson, G., Anderson, K., Wang, W., et al. (2024) · Epilepsia · doi:10.1111/epi.17931 · Cited by 8
Kadam, R., Gupta, M., Lazarov, O., & Prabhakar, B. S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae134 · Cited by 8
Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease
Zheng, F., Dong, T., Chen, Y., Wang, L., & Peng, G. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115021 · Cited by 8
Tolentino, M. J., Tolentino, A. J., Tolentino, E. M., Krishnan, A., & Genead, M. A. (2023) · Pharmaceuticals · doi:10.3390/ph16121735 · Cited by 9
Ahmed, H. H., Mohamed, E. M., & El-dsoki, S. M. (2014) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 8
Downer, E. J., Jones, R. S., McDonald, C., Greco, E., Brennan, S., Connor, T. J., Robertson, I. H., & Lynch, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063194 · Cited by 11
Hamatani, M., Yamashita, H., Ochi, H., Ashida, S., Hashi, Y., Okada, Y., Fujii, C., Kawamura, K., Kitazawa, R., Nakagawa, M., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104867 · Cited by 10
Xu, Z., Lu, W. D., Miao, Y., Li, H., Xie, X., & Zhang, F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106792 · Cited by 9
Novel approach to inhibiting chemokine function
Ling, M. F., & Luster, A. D. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100161 · Cited by 8
Self-citationTherapeutic Approaches for the Treatment of Alzheimer's Disease: An Overview
Lau, L., & Brodney, M. A. (2007) · Springer eBooks · doi:10.1007/7355_2007_017 · Cited by 14
Animal Models of Alzheimer’s Disease
Amram, S., & Frenkel, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00003-x · Cited by 12
Gibbs, M. E., & Gibbs, C. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.070 · Cited by 8
Microglia: A CNS-Specific Tissue Macrophage
Puntambekar, S. S., Doose, J. M., & Carson, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_1 · Cited by 11
Gao, F., Initiative, A. D. N., Zhang, P., Gao, J., Song, J., & Chi, S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220716 · Cited by 8
Helbing, D. L., Haas, F., Cirri, E., Rahnis, N., Dau, T., Sacramento, E. K., Oraha, N., Böhm, L., Lajqi, T., Fehringer, P., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1227355 · Cited by 7
Goll, Y., Bekenstein, U., Barbash, S., Greenberg, D., Zangen, R., Shoham, S., & Soreq, H. (2013) · Neurodegenerative Diseases · doi:10.1159/000353689 · Cited by 8
Chemoattractants and receptors in Alzheimer s disease
Le, Y. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s81 · Cited by 7
Bello, E., Long, K. R., Iwama, S., Steer, J., Cooper, S., Alasoo, K., Kumasaka, N., Schwartzentruber, J., Panousis, N. I., & Bassett, A. R. (2026) · iScience · doi:10.1016/j.isci.2026.115688 · Cited by 7
Fujikawa, R., Yamada, J., Maeda, S., Iinuma, K., Moriyama, G., & Jinno, S. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16133 · Cited by 6
From Organotypic Mouse Brain Slices to Human Alzheimer Plasma Biomarkers: A Focus on Microglia
Steiner, K., Yılmaz, N., Gern, A., Marksteiner, J., Faserl, K., Villunger, M., Sarg, B., & Humpel, C. (2024) · Biomolecules · doi:10.3390/biom14091109 · Cited by 6
Evolution of Alzheimer’s disease pathogenesis conception
Stefanova, N. A., & Kolosova, N. G. (2016) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392516010119 · Cited by 7
Agregados amiloides: rol en desórdenes de conformación proteica
Duran-Aniotz, C. A., Moreno‐González, I., & Morales, R. (2013) · Revista médica de Chile · doi:10.4067/s0034-98872013000400011 · Cited by 6
Li, H., Zou, J., Yao, Z., Yu, J., Wang, H., & Xu, J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.007 · Cited by 7
Adenosine Receptors and Alzheimer’s Disease
Blum, D., Sandau, U. S., Laurent, C., Batalha, V. L., Leboucher, A., Hamdane, M., Pasquier, F., Boison, D., Buée, L., & Lopes, L. V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3903-5_19 · Cited by 6
Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy
Levites, Y., Funk, C. C., Wang, X., Chakrabarty, P., McFarland, K. N., Bramblett, B., O’Neal, V., Liu, X., Ladd, T. B., Robinson, M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00453-4 · Cited by 6
Barbierato, M. (2012) · Padua Research Archive (University of Padova) · Cited by 7
Unveiling the theranostic potential of SPIONs in Alzheimer's disease management
Aminyavari, S., Afshari, A. R., Ahmadi, S. S., Kesharwani, P., Sanati, M., & Sahebkar, A. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.09.022 · Cited by 5
Aging and neurodegeneration: when systemic dysregulations affect brain macrophage heterogeneity
Joly, P., Labsy, R., & Silvin, A. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkae034 · Cited by 6
Role of Leptin and Adiponectin in the Management of Alzheimer's Disease: A Systematic Review
Adil, M., Ghulammohiuddin, F., & Khalid, N. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70326 · Cited by 5
Uemura, K., Hiro, S., Attachaipanich, S., Du, R., Yusof, N. I. S. M., Kinoshita, M., Hikosaka, M., & Ohtsuki, G. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1669272 · Cited by 7
Torok, J., Maia, P. D., Anand, C., & Raj, A. (2025) · Communications Biology · doi:10.1038/s42003-025-07575-1 · Cited by 12
Hiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer’s disease?
Nelson, R. B., Rose, K. N., Menniti, F. S., & Zorn, S. H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116258 · Cited by 6
Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease
Simmons, C. R., Zou, F., Younkin, S. G., & Estus, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-33 · Cited by 6
CD38 AND CD157 EXPRESSION IN THE OLFACTORY BULBS IN EXPERIMENTAL ALZHEIMER’S DISEASE
Komleva, Y. K., Malinovskaya, N. A., Gorina, Y. V., Lopatina, O. L., Volkova, V. V., & Salmina, A. B. (2015) · Siberian medical review · doi:10.20333/25000136-2015-5-44-49 · Cited by 5
Molecular Mechanisms of Acute Brain Injury and Ensuing Neurodegeneration
Francisco, J., Jose, M., Mahy, N., & Manuel, J. (2012) · InTech eBooks · doi:10.5772/37401 · Cited by 5
Generation and characterization of immortalized rat retinal microglial cell lines
Jiang, X., Ni, Y., Liu, T., Zhang, M., Jiang, R., & Xu, G. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23337 · Cited by 5
Gonzalez‐Velasquez, F. J., Reed, J. W., Fuseler, J. W., Matherly, E. E., Kotarek, J. A., Soto-Ortega, D. D., & Moss, M. A. (2010) · Journal of Adhesion Science and Technology · doi:10.1163/016942410x507948 · Cited by 6
Infections with Chlamydia pneumoniae and SARS-CoV-2 and Alzheimer’s disease pathogenesis
Romanella, A., McCall, M., Corwin, R., Faruq, A. A., Lingo, E. G., Bhambhani, S., Hammond, C. J., & Balin, B. J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1587782 · Cited by 6
Wang, W., Chen, Z., Huang, Y., Hu, Z., Zhu, P., Huang, Z., Lv, J., Liao, Z., Zheng, Y., Wei, C., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70608 · Cited by 4
Suswidiantoro, V., Tang, K. S., Rahman, K., Puteri, M. U., Wahyuni, T., Ariestanti, D. M., James, R. J., Yan, C. C., Kato, M., & Saputri, F. C. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101248 · Cited by 5
Alzheimer’s Pathology: Should Peripheral Monocytes and CCR2 Take Center stage?
Harries, L. W., Pilling, L. C., Lampron, A., Rivest, S., & Melzer, D. R. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.72 · Cited by 4
Artelsmair, M., Miranda-Azpiazu, P., Kingston, L. P., Bergare, J., Schou, M., Varrone, A., & Elmore, C. S. (2019) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3731 · Cited by 4
Passive Immunotherapy in Alzheimer’s Disease
Dolan, P. J., & Zago, W. M. (2018) · InTech eBooks · doi:10.5772/intechopen.76299 · Cited by 4
Expression of N-Terminal Cysteine Aβ42 and Conjugation to Generate Fluorescent and Biotinylated Aβ42
Zhang, S., Guaglianone, G., Morris, M. A., Yoo, S., Howitz, W. J., Xing, L., Zheng, J., Jusuf, H., Huizar, G., Lin, J., et al. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00105 · Cited by 4
Xu, L., Fang, Q., Miao, Y., Xu, M., Wang, Y., Sun, L., & Jia, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.1947631 · Cited by 4
Liu, S., Lan, X.-B., Tian, M.-M., Zhu, C., Ma, L., Yang, J.-M., Du, J., Zheng, P., Yu, J.-Q., & Liu, N. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175646 · Cited by 5
Neuroinflammation in Alzheimer's disease
Agrawal, M., Singhal, M., Prajapati, B. G., Chaudhary, H., Jasoria, Y., Kumar, B., Arora, M. K., & Sahoo, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00003-0 · Cited by 5
Computer-Aided Drug Design Approaches to Study Key Therapeutic Targets in Alzheimer’s Disease
Lemos, A., Melo, R., Moreira, I. S., & Cordeiro, M. N. D. S. (2017) · Neuromethods · doi:10.1007/978-1-4939-7404-7_3 · Cited by 4
Kolypetri, P., da Silva, P., Francisco, R. D. S., Frenkel, D., Cecere, R. R., Kiliaan, P. C. J., Montini, F., Saxena, S., Clementi, W. A., Liu, X., et al. (2026) · npj Aging · doi:10.1038/s41514-026-00397-3 · Cited by 3
Vear, A., Olsen, S. A., Lange, E. C. H., Müller, M. A., Svendsen, C., & Clemmensen, C. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102906 · Cited by 3
Yuan, Q., Liu, X., Zhang, Y., Xian, Y., Zou, J., Zhang, X., Huang, P., Song, Y., & Lin, Z. (2021) · Molecules · doi:10.3390/molecules26092685 · Cited by 3
Ramos, J. M. P., Kviatcovsky, D., & Schwartz, M. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15609 · Cited by 3
Davalos, D., Akassoglou, K., & Cardona, A. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00041-2 · Cited by 3
Cimiotti, C. G. V., Paganetti, P., Rossi, S., Soldini, E., & Sacco, L. (2023) · NeuroSci · doi:10.3390/neurosci4040026 · Cited by 3
Neuroprotection Versus Neurotoxicity
Biber, K. P. H., & Block, M. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_6 · Cited by 3
GPCR, a rider of Alzheimer’s disease
Liu, X., & Zhao, J. (2011) · Frontiers in Biology · doi:10.1007/s11515-011-1129-3 · Cited by 3
How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
Donato, L., Mordà, D., Scimone, C., Alibrandi, S., D’Angelo, R., & Sidoti, A. (2023) · Biomedicines · doi:10.3390/biomedicines11072035 · Cited by 3
Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
Hurst, T. P., Coleman-Vaughan, C., Patwal, I., & McCarthy, J. V. (2016) · AIMS molecular science · doi:10.3934/molsci.2016.2.138 · Cited by 2
LeVasseur, H. L., & Zhou, B. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578711 · Cited by 2
Grabon, W., Gasmi, N., Lang, A., Ruiz, A., Georges, B., Blot, V., Ogier, M., Rheims, S., Navarro, F. P., & Bezin, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695856 · Cited by 2
Tognoni, C. M., Biswas, R. G., Suar, Z. M., Carreras, I., Dedeoglu, A., & Jenkins, B. G. (2026) · Scientific Reports · doi:10.1038/s41598-025-32797-y · Cited by 3
Inflammatory Mediators of Alzheimer’s Disease Characterized in a Mouse Model (APP/PS1)
Jorda, A., Alvarez-Gamez, K., Campo-Palacio, I., Campos-Campos, J., Colmena, C., Singh, S. K., Miralles, M. J. C., Aldasoro, C., Aldasoro, M., & Vallés, S. L. (2026) · NeuroSci · doi:10.3390/neurosci7010023 · Cited by 2
Merino, J. J., Rodriguez, J. J., Busquets, X., Álvarez-Vicente, I., Cabaña-Muñoz, M. E., Flores, A. I., & Tolédano, A. (2026) · Biomolecules · doi:10.3390/biom16060855 · Cited by 2
Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
Abellanas, M. A., Basurco, L., Purnapatre, M., Burgaletto, C., Castellani, G., Colaiuta, S. P., Ramos, J. M. P., Ibraheem, A., Murad, S., Antonello, P., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02417-7 · Cited by 3
Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – No
Dutta, R., & Trapp, B. D. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517743094 · Cited by 2
Cardona, A. E., Ransohoff, R. M., & Akassoglou, K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397265-1.00085-x · Cited by 2
Lipid-nanoparticle-induced vacuolization in microglia
Kerschbaum, H., Gerner, C., Oberascher, K., Steiner, P., Schürz, M., & Bresgen, N. (2024) · Communications Biology · doi:10.1038/s42003-024-07271-6 · Cited by 2
Effects of the CC chemokine receptor 2 in mice deficient for the myelin protein zero (P0)
Oberländer, M., & Berghoff, M. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.05.009 · Cited by 2
Skaper, S. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_12 · Cited by 2
Boyd, T. D. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1962 · Cited by 2
Reitz, C., & Tosto, G. (2013) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000060 · Cited by 2
Inflammation in Alzheimer's Disease: Cross-talk between Lipids and Innate Immune Cells of the Brain
Ai, L., & Me, C. (2015) · Cited by 3
Genotype and Sex Differences in Longevity in Transgenic Mouse Models of Alzheimer’s Disease
Brown, R. E., Shin, S., Woodland, N., & Rae, E. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00042-7 · Cited by 4
Neuroinflammation in Age-Related Neurodegenerative Diseases
MacPherson, K. P., Rodrigues, M. E. D. S., Cintron, A. F., & Tansey, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00016-x · Cited by 3
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2
Neuroinflammation in Alzheimer's Disease
(2020) · Case Medical Research · doi:10.31525/ct1-nct04274998 · Cited by 3
Fan, Y., Yang, Y., Lin, K., Zhou, X., Li, Y., & Lin, Q. (2023) · Open Medicine · doi:10.1515/med-2023-0800 · Cited by 2
Sebastian-delaCruz, M. (2025) · Advances in genetics · doi:10.1016/bs.adgen.2025.11.010 · Cited by 1
Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer’s disease
Denver, P., Duffy, A. M., Kennedy, R. T., Gault, V. A., & McClean, P. L. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.038 · Cited by 2
Efferocytosis: Gateway for tissue resolution
Cho, S., & Ju, H. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261431219 · Cited by 1
Maciel, E. M. A., Silva, N. C., Santos, L. G. P., & Ribeiro, F. M. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70416 · Cited by 3
Li, E., Zhang, P., & Feng, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783786 · Cited by 6
Yin, W., Peng, L., Jing-hong, Z., Huang, X., & Yin, W. (2026) · Comprehensive physiology · doi:10.1002/cph4.70146 · Cited by 1
Glial Cells in Brain Defense Mechanisms
Noda, M. (2010) · Neuroimmune biology · doi:10.1016/s1567-7443(10)70019-3 · Cited by 1
Metadata
- Authors
- El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D.
- Affiliations
- Okayama University (JP)
- Northwestern University (US)
- Corresponding author
- Luster, Andrew D
- Venue
- Nature Medicine
- Published
- 2007-03-11
- Volume
- 13
- Issue
- 4
- Pages
- 432-438
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2097867538
- Cited by
- 915
- References
- 51
- Citations by year
- 2026: 29 · 2025: 27 · 2024: 41 · 2023: 35 · 2022: 44 · 2021: 70 · 2020: 51 · 2019: 37 · 2018: 42 · 2017: 51 · 2016: 51 · 2015: 60 · 2014: 43 · 2013: 53 · 2012: 70
- FWCI
- 34.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- Dana Foundation
- Gladstone Institutes
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- CCR2, chemokine receptors, microglia, Alzheimer's disease, amyloid-beta clearance, Tg2576 mice, disease progression, neuroinflammation, gene dosage, neuroprotection
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Brain, Crosses, Genetic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Monocytes, Amyloid beta-Peptides, Microglia, Mice, Knockout, Models, Immunological, Chemokines, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.